Tourmaline Bio Price Prediction
| TRMLDelisted Stock | 47.98 0.00 0.00% |
Momentum 90
Buy Peaked
Oversold | Overbought |
Using Tourmaline Bio hype-based prediction, you can estimate the value of Tourmaline Bio from the perspective of Tourmaline Bio response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Tourmaline Bio to buy its stock at a price that has no basis in reality. In that case, they are not buying Tourmaline because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Tourmaline Bio after-hype prediction price | USD 47.98 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as delisted stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Tourmaline |
Tourmaline Bio After-Hype Price Density Analysis
As far as predicting the price of Tourmaline Bio at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Tourmaline Bio or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Tourmaline Bio, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Tourmaline Bio Estimiated After-Hype Price Volatility
In the context of predicting Tourmaline Bio's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Tourmaline Bio's historical news coverage. Tourmaline Bio's after-hype downside and upside margins for the prediction period are 47.98 and 47.98, respectively. We have considered Tourmaline Bio's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Tourmaline Bio is very steady at this time. Analysis and calculation of next after-hype price of Tourmaline Bio is based on 3 months time horizon.
Tourmaline Bio Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Tourmaline Bio is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Tourmaline Bio backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Delisted Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Tourmaline Bio, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.00 | 0.00 | 0.00 | 0.00 | 4 Events / Month | 7 Events / Month | In about 4 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
47.98 | 47.98 | 0.00 |
|
Tourmaline Bio Hype Timeline
Tourmaline Bio is at this time traded for 47.98. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Tourmaline is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is expected to be very small, whereas the daily expected return is at this time at 0.0%. %. The volatility of related hype on Tourmaline Bio is about 0.0%, with the expected price after the next announcement by competition of 47.98. About 15.0% of the company outstanding shares are owned by corporate insiders. The book value of Tourmaline Bio was at this time reported as 10.09. The company recorded a loss per share of 3.44. Tourmaline Bio last dividend was issued on the 20th of October 2023. The entity had 1:10 split on the 20th of October 2023. Given the investment horizon of 90 days the next expected press release will be in about 4 days. Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.Tourmaline Bio Related Hype Analysis
Having access to credible news sources related to Tourmaline Bio's direct competition is more important than ever and may enhance your ability to predict Tourmaline Bio's future price movements. Getting to know how Tourmaline Bio's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Tourmaline Bio may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| TERN | Terns Pharmaceuticals | (0.32) | 11 per month | 2.50 | 0.24 | 13.30 | (6.06) | 76.18 | |
| PGEN | Precigen | 0.17 | 9 per month | 4.59 | 0.05 | 8.52 | (7.08) | 38.64 | |
| IMTX | Immatics NV | (0.13) | 7 per month | 3.80 | (0) | 7.31 | (6.47) | 30.34 | |
| ORIC | Oric Pharmaceuticals | 0.17 | 16 per month | 2.99 | (0) | 6.63 | (4.36) | 15.34 | |
| ELVN | Enliven Therapeutics | 0.17 | 3 per month | 4.46 | 0.06 | 6.28 | (7.81) | 54.92 | |
| AMLX | Amylyx Pharmaceuticals | 0.08 | 9 per month | 3.00 | (0.01) | 8.11 | (4.94) | 19.81 | |
| RLAY | Relay Therapeutics | 0.17 | 3 per month | 3.25 | 0.03 | 5.60 | (5.45) | 27.25 | |
| DNTH | Dianthus Therapeutics | (0.31) | 11 per month | 2.30 | 0.15 | 8.00 | (4.47) | 22.10 | |
| WVE | Wave Life Sciences | 0.17 | 3 per month | 3.99 | 0.1 | 8.92 | (6.68) | 164.47 | |
| SNDX | Syndax Pharmaceuticals | 0.17 | 3 per month | 2.30 | 0.13 | 8.70 | (3.59) | 18.37 |
Tourmaline Bio Additional Predictive Modules
Most predictive techniques to examine Tourmaline price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Tourmaline using various technical indicators. When you analyze Tourmaline charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Tourmaline Bio Predictive Indicators
The successful prediction of Tourmaline Bio stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Tourmaline Bio, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Tourmaline Bio based on analysis of Tourmaline Bio hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Tourmaline Bio's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Tourmaline Bio's related companies.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Other Consideration for investing in Tourmaline Stock
If you are still planning to invest in Tourmaline Bio check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tourmaline Bio's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |